A California-based biotech company is turning heads during Tuesday’s session after the company announced its phase 2b COVID-19 trial received Independent Data Safety...

To read the full story on AllPennyStocks.com, click here.

Vaxart (NASDAQ:VXRT)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025 Plus de graphiques de la Bourse Vaxart
Vaxart (NASDAQ:VXRT)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025 Plus de graphiques de la Bourse Vaxart